The bid launched by Clessidra Capital Partners and Avista Capital Partners for Italian drugmaker Rottapharm has ground to a halt due to share governance issues and fundraising difficulties.
Sale of Italian printed circuit boards marks second exit of Milan-based GP’s Fund 3
Belgian VC held first close for debut vehicle on EUR 75m with commitments from PMV, EIF
Verium I SCS, which closed on CHF 120m, is the family office's first LP-backed fund
Informal talks held with potential bidders in the summer; EUR 60m debt line arranged last month